Hillary Rodham Clinton’s plan to rein in prescription drug prices by reshaping how drugmakers do business is being met by skepticism within the industry. Pharmaceutical experts are mostly shrugging off the proposal from the Democratic presidential candidate, which she outlined Tuesday at a forum in Iowa.
Are you up for a challenge?
